Stock CYCC CYCLACEL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cyclacel Pharmaceuticals, Inc.

Equities

CYCC

US23254L8019

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.51 USD -5.62% Intraday chart for Cyclacel Pharmaceuticals, Inc. -15.17% -43.45%
Apr. 01 Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer CI
Mar. 19 Transcript : Cyclacel Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 19, 2024

Evolution of the average Target Price on Cyclacel Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a6624e5cd494b53d5a3b1b4194e9a.vJPT_XFUF77QtYE98RFcihAxEWZW8THH6Fgv7eitqdU.idGBsjcjQeeI0tVfvWhl_iMFWRI6olKThQ5pgavH3O394b6EATtzzZjv8g~7990313aacfdd2772af20b09e45910f5

Analyst Recommendations on Cyclacel Pharmaceuticals, Inc.

Brookline Capital Downgrades Cyclacel Pharmaceuticals to Hold From Buy MT
Oppenheimer Adjusts Cyclacel Pharmaceuticals Price Target to $8 From $10, Maintains Outperform Rating MT
Oppenheimer Adjusts Cyclacel Pharmaceuticals Price Target to $10 From $17, Maintains Outperform Rating MT
Roth Capital Adjusts Cyclacel Pharmaceuticals Price Target to $16 From $24, Maintains Buy Rating MT
CYCLACEL PHARMACEUTICALS : Oppenheimer Initiates Cyclacel Pharmaceuticals at Outperform Rating With $17 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.51 USD
Average target price
163 USD
Spread / Average Target
+10,694.70%
High Price Target
315 USD
Spread / Highest target
+20,760.92%
Low Price Target
11 USD
Spread / Lowest Target
+628.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cyclacel Pharmaceuticals, Inc.

Brookline Capital Markets
Oppenheimer
Roth Capital Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Consensus Cyclacel Pharmaceuticals, Inc.